This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Eckert & Ziegler has entered into an agreement with Actinium Pharmaceuticals to supply the firm with the radioisotope actinium-225 (Ac-225). and international clinical trials.
Shuttle Pharmaceuticals Holdings has closed a previously announced underwritten public common stock offering, with aggregate gross proceeds of approximately $5.8 The Gaithersburg, MD-based specialty pharmaceutical company offered 19.1 million shares of its common stock at a public offering price of 30 per share.
Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine. Telix said these new therapeutic assets are differentiated by a structure that drives extended tumor retention while minimizing off-target uptake.
The group analyzed flortaucipir (Tauvid, Avid Pharmaceuticals) PET scans acquired over a 3.5-year Participants were clinically unimpaired and between ages 51 and 89 at the beginning of the study. The researchers aimed to investigate whether menopausal HT use is associated with later-life tau accumulation.
Read more on AuntMinnie.com Related Reading: Clarity advances dose escalation for cohort in SECuRE trial Clarity reaches 50% recruitment for SABRE trial NorthStar and Bayer reach Ac-225 supply deal NorthStar manufactures Cu-67 for Clarity Pharmaceuticals NorthStar appoints new president/CEO
We are excited, in collaboration with 3BP and others, to advance this molecule through clinical testing to commercialization.” milla1cf Wed, 09/20/2023 - 09:56 September 20, 2023 — RefleXion Medical , Inc., Our partnership with 3BP is as unprecedented in the external-beam radiotherapy industry as our SCINTIX therapy is for cancer treatment.
Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than Intravascular ultrasound (IVUS), making it ideal for clinical trials of cardi
A PET radiotracer that detects clear-cell renal cell carcinoma proved safe and effective in a clinical trial conducted at 36 research hospitals across nine countries, according to a study published September 10 in the Lancet Oncology. The full study is available here.
Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.
It’s also primed to revolutionize the pharmaceutical industry. Pharma companies that truly embrace AI can run parallel clinical trials for the same drug as a single agent or in combinations targeting multiple diseases where the drug is predicted to work. Many pharma companies have changed their CEOs at least once.
He will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy. He has spent more than two decades working for pharmaceutical companies such as Bayer, Bristol-Myers Squibb, Kyowa Kirin, and Pfizer.
Produced by the ACR Committee on Drugs and Contrast Media, the new manual features four updates: An update and addition of Ferumoxytol as a new MRI contrast medium for Chapter 12 – Contrast Media in Children An update for Chapter 13 - Gastrointestinal (GI) Contrast Media in Adults: Indications and Guidelines An evidence-based update with recommendations (..)
Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.
GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 billion in the same period last year.
Under the agreement, EBG-USA and AbbVie will collaborate with EBG-USA’s academic and pharmaceutical partner network to validate preclinical and clinical PET ligands during an initial evaluation period.
Telix Pharmaceuticals plans to spin off its wholly-owned subsidiary Rhine Pharma and structure it as an independent company. The collaboration resulted in a potential theranostic compound, RHN0014, which the company is now advancing into a phase I/IIa clinical study.
will unveil its AI-powered lung cancer continuum at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, from May 31 to June 4. The end-to-end care continuum is designed to support clinicians and promote developments for lung health in the pharmaceutical and medical device industries.
ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.
Telix Pharmaceuticals has submitted a Biologics License Application (BLA) to the U.S. and a named-patient program in Europe to allow access to Zircaix outside of clinical trials to patients for whom there are no comparable or satisfactory alternate options. It has also requested priority review.
Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S., FES PET, like FDG PET, is now included in the NCCN Guidelines. The NCCN is a not-for-profit alliance of 33 leading U.S.
TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. The life expectancy of patients on the personalized dosimetry arm of the trial increased to 26.6 months from 10.7
and Project Data Sphere, a nonprofit initiative of the CEO Roundtable on Cancer, are partnering to improve tumor assessments using AI-enabled tools for clinical trials and cancer care. Food and Drug Administration (FDA), includes stakeholders and experts from across the pharmaceutical industry and academia.
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients.
Telix Pharmaceuticals and the Brussels-based Oncidium foundation are highlighting results from the NOBLE Registry of TLX599-CDx (technetium-99m [Tc-99m] inhibitor of prostate-specific membrane antigen [iPSMA]), published in the European Journal of Nuclear Medicine and Molecular Imaging Reports.
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., Proceduralists must refer to standard of care imaging and prioritize clinical experience and/or judgment when using the OmnifyXR system.
Food and Drug Administration (FDA) has opened an expanded access program for Telix Pharmaceuticals' PET radiotracer TLX101-CDx (Pixclara, F-18 floretyrosine) for imaging progressive or recurring gliomas. Telix plans to file a new drug application with the FDA for radiotracer in the third quarter of this year, it said.
"Somebody on the other end of the spectrum might say a theranostics center represents a clinical practice where patients are administered a radiopharmaceutical, with any diagnostic imaging sent out to those who do diagnostic imaging, and then these patients are sent back for clinical care to their medical oncologist for all follow-up," he added.
The Evanston, IL-based company specializes in delivering dosimetry analysis and treatment plans to clinical research organizations and pharmaceutical manufacturers. The company offers scalable dosimetry services that integrate with existing imaging workflows in hospitals and cancer treatment research facilities.
BJH/WU's joint theranostics program provides a full range of theranostic services, including diagnostic imaging, consultation, radiopharmaceutical infusions for both clinical and research treatments, and follow-up evaluations. Nuclear Regulatory Commission and is an integral part of a theranostics practice.
AI imaging firm Brainomix has entered into a partnership with German pharmaceutical company Boehringer Ingelheim to improve the care of U.S. patients with fibrosing lung disease. Through the partnership, Brainomix will deploy its e-Lung software, which has 510(k) clearance from the U.S. Food and Drug Administration (FDA), to U.S.
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.
Based on this agreement, GE HealthCare will take on global rights for [68Ga]FAPI-46 and outside-US rights for [18F]FAPI-74, originally developed at Heidelberg University in Germany, and both currently in Phase II clinical trials in the U.S. 68Ga]FAPI-46 (NCT05262855)2 and [18F]FAPI-74 (NCT05641896)3). Sherly Mosessian , Ph.D,
His research has led to the translation of several novel radiopharmaceuticals into clinical use, including 11C-YJH08 (targeting the glucocorticoid receptor), Cu-64 GRIP B (targeting granzyme B), and F-18 TRX (targeting ferrous iron). Evans earned his PhD in organic chemistry from the Scripps Research Institute.
An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions. BWXT Medical’s Ac-225 has been used in an early clinical study, and the DMF is now ready for reference to support later stage clinical studies and, ultimately, new drug applications.
Radiologists in Ukraine have shared stories on their experiences, from living in the basement of their respective clinics to treat patients while evading bombings, to adjusting their workflows to continue delivering care.
The research will produce technical feedback to assist GEHC in assessing the system’s reconstruction methods, image presentation workflow, and clinical benefits for specific pathologies and disease types. MRI GEHC unveiled Signa Champion, a 1.5-tesla,
Clinical trials for MASH drugs rely on various imaging modalities to provide quantitative and qualitative data regarding liver health, fat content, fibrosis, and inflammation. In obesity management, for instance, imaging techniques can offer precise measurements of visceral fat, enabling tailored treatment plans and monitoring progress.
Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Clinical research and commercial use of Ac-225 have been constrained by chronic short supply due to limitations of current production technology. Under terms of the agreement, NorthStar will supply its high purity, non-carrier added (n.c.a.)
Multimodal, Patient-Centric Registries Accelerate Clinical Trial Enrollment Decisions Once efficiency gains are realized by streamlining noninterpretive, “mundane” imaging curation processes with AI, health systems can begin to build “gold standard” stores of radiology data that are pre-labeled and tagged.
Curadh), a global MTR focused clinical, research and advisory organization, announced the signing of a strategic long term supply agreement for the therapeutic radioisotope non-carrier added (n.c.a.) Ac-225 and copper-67 (Cu-67) for advancing clinical research and commercial radiopharmaceutical therapy products.
mtaschetta-millane Wed, 07/24/2024 - 11:17 July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Through this NDA, Telix's objective is to further enhance patient access to PSMA-PET imaging and the clinical benefits of 68Ga imaging to underserved populations across the U.S., Accessed May 2024. [7]
The project is the second funded and supported by NEURii, a global collaboration between the pharmaceutical company Eisai, Gates Ventures, the University of Edinburgh, the medical research charity LifeArc and the national health data science institute Health Data Research UK.
Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content